|
|
||||||||
Ann Thorac Surg 2004;78:1268-1273
© 2004 The Society of Thoracic Surgeons
Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi,Kurume, 830-0011Japan
Accepted for publication February 10, 2004.
* Address reprint requests to Dr Onitsuka, Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan
onitti{at}med.kurume-u.ac.jp
| Abstract |
|---|
|
|
|---|
METHODS: Seventy-six medically treated patients with acute type B aortic dissection were examined between 1990 and 2001. The events associated with aortic dissection included dissection-related death, rupture, visceral ischemia, lower limb ischemia, an increase in the maximum aortic diameter greater than 50 mm, and a mean enlargement rate of greater than 5 mm per year.
RESULTS: Among the 76 patients 10 (13%) underwent chronic phase surgery and 25 (33%) presented with an event. A statistically significant difference was observed between patients with and without events with regard to atherosclerotic factors, blood flow status in the false lumen, maximum aortic diameter upon admission, mean aortic enlargement rate, and blood pressure control during follow-up. Of these factors a patent false-lumen and a maximum aortic diameter greater than 40 mm upon admission were the most strongly associated factors with regard to the development of events. Patients with a patent false-lumen and a maximum aortic diameter greater than 40 mm upon admission were determined to exhibit significantly higher event rates than other patients.
CONCLUSIONS: In determining the appropriate therapeutic approach for acute type B aortic dissection, it is important to pay careful attention to the predictors of a patent false-lumen and a maximum aortic diameter greater than 40 mm at onset to improve the long-term outcome.
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
Definitions
"Acute" describes the period within 14 days of the onset of symptoms. "Chronic" describes the situation at least 14 days after the onset of symptoms. The diagnosis was established based on the findings of computed tomography (CT) in all of the patients and digital subtraction angiography (DSA) was performed on those patients with dissection-related complications. Aortic dissections were morphologically classified according to the Stanford (type A, type B) and DeBakey classification (IIIa, IIIb).
Based on the findings regarding the blood flow status in the false lumen obtained by initial CT and DSA, aortic dissections were classified as two types: the early thrombosed false-lumen and the patent false-lumen. In the early thrombosed false-lumen, the false lumen is completely thrombosed and indicates no enhancement. Patients with an ulcer-like projection (ULP) were included in the early thrombosed false-lumen. In the patent false-lumen, blood flow is seen in the false lumen that communicates with the true lumen forming a so-called "double-barrel" aorta. Even if the false lumen were partially thrombosed, the dissection was classified as the patent false-lumen if the contrast agent flowed into the false lumen and extended to central or peripheral areas.
The largest diameter of the dissecting aorta measured on CT images was defined as the maximum aortic diameter (mm). The maximum aortic diameter was measured twiceon the initial CT images obtained upon admission and on the most recent CT images. In patients who underwent surgery during either the acute or chronic phase, the diameter was measured on CT images obtained immediately before surgery. The mean aortic enlargement rate (mm per year) was obtained by dividing the difference in maximum aortic diameter between the initial CT images obtained upon admission and the most recent CT images (mm) by the interval (years) between the initial and most recent CT images. The mean aortic enlargement rate was calculated only when the initial CT images were obtained at least 1 year before the most recent CT images.
Patients were determined to exhibit atherosclerotic factors when they presented with (or indicated a history of) any of the following diseases: hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, and cerebrovascular disease. Patients who exhibited a history of smoking before onset were classified as "smokers."
Control of blood pressure during the follow-up phase was evaluated based on blood pressure measurements obtained at outpatient clinics at intervals of 2 weeks to 1 month. Control of blood pressure was judged to be favorable when the mean systolic blood pressure was maintained at less than 140 mm Hg and the diastolic blood pressure at less than 90 mm Hg. Otherwise, blood pressure control was judged to be poor.
The complications associated with aortic dissection included dissection-related death, rupture or impending rupture, visceral ischemia, lower limb ischemia, an increase in the maximum aortic diameter greater than 50 mm, and a mean aortic enlargement rate of greater than 5 mm per year. The development of any of these complications was designated as the "event group," and those who did not experience any of these complications were designated as the "nonevent group."
Characteristics
The most commonly observed comorbidity was hypertension, which was observed in 58 patients (76%), followed by chronic heart failure in 9 patients (12%), cerebrovascular disease in 5 patients (7%), operation for cardiovascular disease in 4 patients (5%), malignancy in 4 patients (5%), chronic renal insufficiency in 3 patients (4%) (2 dialysis patients), chronic hepatitis in 2 patients (3%), chronic obstructive pulmonary disease in 2 patients (3%), diabetes mellitus in 2 patients (3%), chronic rheumatoid arthritis in 2 patients (3%), and hyperlipidemia in 1 patient (1%) (Table 1). In our study population, no patients were determined to exhibit Marfan's syndrome, traumatic dissection, or iatrogenic dissection.
|
-blockers and angiotensin-converting enzyme inhibitors as appropriate. While maintaining adequate urine production, blood pressure was controlled with a target systolic blood pressure of 120 mm Hg. After discharge, patients continued to receive oral medications at a local clinic or at our hospital. In addition, surgery was performed in patients with complications such as rupture or impending rupture, an increased aortic diameter, visceral ischemia, and lower limb ischemia. Follow-up was obtained by a review of hospital charts and office records, in-person office visits, and telephone and letter interviews with the patients or their families.
Statistical Analysis
In the statistical analysis, comparisons between the event group and nonevent group were performed using the unpaired Student's t test for continuous measures and the
2 test for nominal variables. For 2 x 2 contingency tables, the
2 test or Fisher's direct method was used. In multivariate analysis, logistic regression was employed. The event-free rate was analyzed by the KaplanMeier method and comparisons between groups were performed using the log-rank test as well as the BreslowGehanWilcoxon test. In addition, changes in maximum aortic diameter over time were evaluated using a regression line. In comparisons between two groups, a risk factor p value less than 0.05 was considered statistically significant. In comparisons between four groups, a Bonferroni comparison method was employed to avoid type I errors, and a risk factor p value less than 0.008 was considered statistically significant. Values are indicated as mean ± standard deviation.
| Results |
|---|
|
|
|---|
Acute phase surgery was performed in 2 patients with rupture and 2 patients with visceral ischemia involving the superior mesenteric artery and the renal artery. Of these, a total of 3 patients (75%) died during hospitalization: the 2 patients with rupture and 1 patient with occlusion of the superior mesenteric artery. The remaining patient with renal ischemia underwent right axillary-femoral bypass surgery and indicated improved renal function and an increase in urinary volume after surgery. One year later, however, this patient's maximum aortic diameter has increased to 60 mm and surgery has been scheduled.
Chronic phase surgery was performed in 6 patients with increased aortic diameter, 1 patient with rupture of the false lumen of the left iliac artery, 1 patient with impending rupture, 1 patient with visceral ischemia, and 1 patient with lower limb ischemia. Of these 10, 3 patients (30%) who underwent graft replacement for an increase in aortic diameter died during hospitalization.
Among the 66 patients in whom medical treatment was continued during the chronic phase, 50 (76%) of them survived and 14 died. The other 2 patients were lost to follow-up (follow-up was 97.5% complete). Of the 14 patients who died, 4 experienced dissection-related deaths: rupture in 2 patients and sudden death, in 2 patients. In both cases of rupture-induced death the patients had refused to undergo surgery. The other 10 deaths were caused by other factors: acute myocardial infarction in 4 patients, subarachnoid hemorrhage in 1 patient, cerebral stroke in 1 patient, malignancy in 3 patients, and postoperative complications of DeBakey type I aorta dissection in 1 patient.
Examination of Events
Among the 76 patients selected for acute phase medical treatment, 25 (33%) experienced events. The event-free rate was 73% at 5 years (Fig 1). Specifically, these events included dissection-related death in 4 patients, rupture or impending rupture in 5 patients, visceral ischemia in 3 patients, lower limb ischemia in 2 patients, an increase in the maximum aortic diameter greater than 50 mm in 17 patients, and a mean aortic enlargement rate of greater than 5 mm per year in 5 patients, for a total of 36 events in 25 patients. Of these 25 patients, 11 (44%) underwent surgery. Among the 66 patients who did not undergo surgery during the chronic phase, 15 (23%) of them experienced events.
|
|
|
|
| Comment |
|---|
|
|
|---|
In this study, among the 81 patients with acute type B aortic dissection, 76 of them received conservative medical treatment during the acute phase and 66 of them continued to receive medical treatment during the chronic phase. Of these patients 50 (76%) survived. Given these results, can such conservative therapies be considered effective? During conservative treatment 4 patients experienced rupture and sudden death and 10 patients required surgery during the chronic phase. In addition the surgical morbidity and mortality incidences during this chronic phase were high (30%). Some of the other patients who are still receiving conservative treatment are also expected to meet the conditions for surgery during the follow-up period. If it were possible to identify the patients with predictors of dissection-related complications requiring surgery at the time of onset the therapeutic outcome for patients with type B aortic dissections would be expected to improve.
In general, when conservative treatment is selected for patients with acute type B aortic dissection these patients tend to exhibit a comparatively favorable prognosis [8, 11] comparable with that of patients undergoing surgery during the acute phase [4, 12]. However it must be kept in mind that the surgical outcome tends to be poor when the patient is admitted with rupture, visceral ischemia, and lower limb ischemia or when the patient exhibits critical organ failure [3, 5, 9, 13, 14]. It follows that these confounding factors must be eliminated when therapeutic outcomes between the surgical therapy group and the conservative therapy group in patients with type B aortic dissection are compared [5, 7, 12, 14, 15].
The present study examined patients with acute type B aortic dissection who experienced the following six events after onset: dissection-related death, rupture or impending rupture, visceral ischemia, lower limb ischemia, an increase in the maximum aortic diameter greater than 50 mm, and a mean aortic enlargement rate of greater than 5 mm per year. These six events suggested that it was necessary to perform or consider surgery during follow-up. Correlations were evaluated between the occurrence of these events and various factors (ie, gender, age, atherosclerotic factors, smoking history, DeBakey classification, blood flow status in the false lumen, maximum aortic diameter upon admission, mean aortic enlargement rate, ULP, and blood pressure control during follow-up). In other words if these predictors are significantly correlated with the occurrence of events it may be possible to anticipate the necessity for surgical treatment in the chronic phase before the patient satisfies the current criteria for surgical intervention.
Compared with the nonevent group, the event group included a significantly larger number of patients with atherosclerotic factors, patent false-lumen, maximum aortic diameter greater than 40 mm upon admission, and poor blood pressure control during follow-up. The event group also exhibited a significantly larger maximum aortic diameter upon admission and an increased mean aortic enlargement rate compared with the nonevent group. In particular, among those patients who exhibited both a patent false-lumen and a maximum aortic diameter greater than 40 mm upon admission (which were the predictive factors identified by multivariate analysis), greater than 50% experienced events within approximately 5 years. Among the 29 patients who exhibited both thrombosed false-lumen and maximum aortic diameter less than 40 mm upon admission, only 2 (6.9%) of them experienced events during follow-up. Dissection-related complications, such as visceral ischemia and lower limb ischemia, are likely to develop in patients with patent false-lumen. These patients also tend to indicate an increase in maximum aortic diameter.
In conclusion one of the most important factors with regard to improving the prognosis of patients with acute type B aortic dissection is to establish the diagnosis as soon as the patient arrives at the hospital. Based on the findings of physical examination as well as CT, angiographic, and ultrasonographic studies, a valid attempt should be made to accurately determine whether or not emergency surgery is required for rupture, visceral ischemia, or lower limb ischemia and the formulation of a treatment plan should be administered without delay. When conservative medical treatment is selected for patients without dissection-related complications a treatment plan should be formulated according to the blood flow status in the false lumen and the maximum aortic diameter that can be confirmed immediately after onset [16, 17]. When conservative treatment is selected in a patient with atherosclerotic factors who exhibits both the patent false-lumen and a maximum aortic diameter greater than 40 mm upon admission, appropriate blood pressure control and careful CT examination should be performed during follow-up to monitor for potential dissection-related complications. In addition if the patient presents rapid aortic enlargement and poor blood pressure control during follow-up, surgical intervention in the comparatively early phase may be considered.
The recommendations in this report are provisory. An inherent limitation concerning the present study is that it is a retrospective nonrandomized review. It is necessary that we accumulate more experience and more long-term patient follow-up to reassess the predictors influencing the therapeutic outcome of patients with acute type B aortic dissection. Then if those predictors revealed are significantly correlated with the occurrence of dissection-related complications, it may possible to change the management plan and the therapeutic outcome of patients with acute type B aortic dissection can be expected to improve.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. A. Anderson, E. Rodriguez, M. C. Stoner, and A. P. Kypson Delayed type A dissection after arch transposition and stent graft therapy of a type B dissection J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 1031 - 1032. [Full Text] [PDF] |
||||
![]() |
K. J. Blount and K. D. Hagspiel Aortic Diameter, True Lumen, and False Lumen Growth Rates in Chronic Type B Aortic Dissection Am. J. Roentgenol., May 1, 2009; 192(5): W222 - W229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Farber Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med. 2007;357:349-359 Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 316 - 318. [PDF] |
||||
![]() |
A. B. Lumsden and M. J. Reardon Once Dissected Always Dissected! Can Stent Grafts Change the Natural History of Type B Dissections?: A Report From the International Registry of Acute Aortic Dissection J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 403 - 404. [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, N. T. Kouchoukos, D. C. Miller, J. E. Bavaria, J. S. Coselli, M. A. Curi, H. Eggebrecht, J. A. Elefteriades, R. Erbel, T. G. Gleason, et al. Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts Ann. Thorac. Surg., January 1, 2008; 85(1_Supplement): S1 - S41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schoder, M. Czerny, M. Cejna, T. Rand, A. Stadler, G. H. Sodeck, R. Gottardi, C. Loewe, and J. Lammer Endovascular Repair of Acute Type B Aortic Dissection: Long-Term Follow-Up of True and False Lumen Diameter Changes Ann. Thorac. Surg., March 1, 2007; 83(3): 1059 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Che, J. Chen, L. Liu, and Q. Zhou Rupture of aorta arch aneurysm into the lung with formation of pseudoaneurysm Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 55 - 57. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |